Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours Β· Estimated delivery Oct 9 - Oct 14
10.1038/s41569-024-01076-0 226
Regulatory update (August 2026): PCAC voted 86 to recommend BPC-157 for the 503A Bulk Drug Substances List at the July 23, 2026 hearing, overriding FDA staffs own recommendation
gim np nhn v tng sc t lm p da
Both peptides bind to the Growth Hormone Secretagogue Receptor type 1a (GHS-R1a) on pituitary somatotropes, triggering pulsatile GH release
This strategic combination allows researchers to study how structural repair (BPC-157), inflammation control (KPV), cellular migration (TB-500), and collagen remodeling (GHK-Cu) interact synergisticallymaking it uniquely valuable for comprehensive tissue repair studies where multiple systems need investigation simultaneously
US$ 28.88
US$ 28.49
US$ 21.59
